Index of Articles From The National Institute of Allergy and Infectious Diseases
Statement of Anthony S. Fauci, M.D. Director, National Institute of Allergy and Infectious Diseases, National Institutes of Health on National HIV Testing Day, June 27, 2009 NIAID Leaders Outline Research Agenda for Universal, Voluntary HIV Testing and Treatment Starting Antiretroviral Therapy Earlier Yields Better Clinical Outcomes Questions and Answers: The CIPRA HT 001 Clinical Trial National Asian and Pacific Islander HIV/AIDS Awareness Day HIV Vaccine Awareness Day Male Circumcision Reduces Risk of Genital Herpes and HPV Infection, but Not Syphilis Statement of Christine F. Sizemore, Ph.D., Barbara E. Laughon, Ph.D., and Anthony S. Fauci, M.D., on World TB Day Experimental Vaccine Shows Promise in Preventing Cytomegalovirus Infection National Native HIV/AIDS Awareness Day: March 20, 2009 IL-2 Immunotherapy Fails to Benefit HIV-Infected Individuals Already Taking Antiretrovirals Anti-HIV Gel Shows Promise in Large-Scale Study in Women Statement of Anthony S. Fauci, M.D., on National Black HIV/AIDS Awareness and Information Day, February 7, 2009 Statement of Anthony S. Fauci, M.D., on the Death of Martin Delaney NIAID Honors AIDS Activist Martin Delaney How HIV Causes AIDS
Well-Armed Immune Cells Help Long-Term Non-Progressors Contain HIV Statement of Anthony S. Fauci, M.D., Director, National Institute of Allergy and Infectious Diseases, National Institutes of Health, on National Latino AIDS Awareness Day, October 15, 2008 Study Reveals Link Between Apobec3 Gene and Neutralizing Antibody Response to Retrovirus Nominations for New Scientific/Clinical Members for the Department of Health and Human Services (DHHS) Panel on Antiretroviral Guidelines for Adults and Adolescents Now Being Accepted Exhausted B Cells Hamper Immune Response to HIV Monitoring Board Recommends Stopping Experimental Treatment Regimen in International Study of Patients New to HIV Treatment Statement of Anthony S. Fauci, M.D., on HIV Vaccine Awareness Day Dr. Anthony Fauci Reflects on 25 Years of HIV Insights From People Who Keep HIV in Check Naturally TB Genome Knowledge May Lead to Improved Diagnosis National Women and Girls HIV/AIDS Awareness Day NIAID Modifies HIV Antiretroviral Treatment Study NIAID Scientists Identify New Cellular Receptor for HIV Statement of Anthony S. Fauci, M.D., on National Black HIV/AIDS Awareness and Information Day Questions and Answers: The HPTN 039 HIV Prevention/Herpes Suppression Study
Advertisement
An Update Regarding the HVTN 502 and HVTN 503 HIV Vaccine Trials Questions and Answers: HVTN 502 and HVTN 503 HIV Vaccine Clinical Trials Study Finds Genetic Influence on Pace of HIV/AIDS Progression HIV Infection in Adolescents and Young Adults in the U.S. Key Points About STIs in the United States Chlamydia Fact Sheet Gonorrhea Fact Sheet NIAID Statement on HIV Vaccine Awareness Day The Quest for an Effective HIV Vaccine Presents New Possibilities, Challenges Statement of Anthony S. Fauci, M.D., Director, National Institute of Allergy and Infectious Diseases National Institutes of Health on National Women and Girls HIV/AIDS Awareness Day, March 10, 2007 Scientists Unveil Piece of HIV Protein That May Be Key to AIDS Vaccine Development Statement of Anthony S. Fauci, M.D., Director, National Institute of Allergy and Infectious Diseases, National Institutes of Health on National Black HIV/AIDS Awareness and Information Day
Questions and Answers: NIAID-Sponsored Adult Male Circumcision Trials in Kenya and Uganda Adult Male Circumcision Significantly Reduces Risk of Acquiring HIV Syphilis NIAID Announces New Campaign to Raise Awareness of Preventive HIV Vaccine Research AIDS Drugs Have Saved 3 Million Years of Life in the United States Statement of Elias A. Zerhouni, M.D., Jack Whitescarver, Ph.D., and Anthony S. Fauci, M.D., National Institutes of Health on the 25th Anniversary of the First Published Reports of AIDS African Americans: Answers About HIV Vaccine Research here
NIAID Statement on HIV Vaccine Awareness Day, May 18, 2006 HIV Infection in Women Statement of Anthony S. Fauci, M.D., Director, National Institute of Allergy and Infectious Diseases, National Institutes of Health, on National Women and Girls HIV/AIDS Awareness Day, March 10, 2006 Statement of Anthony S. Fauci, M.D., Director, National Institute of Allergy and Infectious Diseases, National Institutes of Health, on National Black HIV/AIDS Awareness and Information Day 2006 International HIV/AIDS Trial Finds Continuous Antiretroviral Therapy Superior to Episodic Therapy here
Questions and Answers: A Large International HIV/AIDS Study Comparing Two Strategies for Management of Anti-Retroviral Therapy (The SMART Study) here
Statement from the National Institutes of Health on World AIDS Day: "Action Makes A Difference" National Latino AIDS Awareness Day, October 15, 2005 NIAID Launches First Phase II Trial of a "Global" HIV/AIDS Vaccine NIAID Responds to Hurricane Katrina Survey Uncovers Surprising Attitudes Towards HIV Vaccine Research New Agreement Will Speed Research Efforts on Microbicides for Women NIAID Funds Center for HIV/AIDS Vaccine Immunology (CHAVI) Human Cells Can "Silence" HIV Genes HIV Vaccine Awareness Day Men Inspiring Hope: HIV Vaccine Awareness Day, May 18th Statement of Anthony S. Fauci, M.D. Director, National Institute of Allergy and Infectious Diseases on National Asian and Pacific Islander HIV/AIDS Awareness Day National Black HIV/AIDS Awareness and Information Day -- Statement of Anthony S. Fauci, M.D. HIV Vaccines: Questions and Answers for HIV Treatment Advocates NIAID Begins Enrolling Volunteers for Novel HIV Vaccine Study Scientists Discover Key Genetic Factor in Determining HIV/AIDS Risk HIV Vaccines Explained African Americans: Answers About HIV Vaccine Research here
Women: Answers About HIV Vaccine Research here
Health Care Professionals: Answers About HIV Vaccine Research here
The HIVNET 012 Study and the Safety and Effectiveness of Nevirapine in Preventing Mother-to-Infant Transmission of HIV NIAID Forms Clinical Consortium to Improve Success of Organ Transplants Fauci to Present Research Update at World AIDS Conference in Bangkok HIV Infection in Infants and Children Weekly Cycles of Once-Daily Anti-HIV Drugs Could Reduce Cost of HIV Treatment Challenges in Designing HIV Vaccines HIV Patients Get Long-Term Boost With Short, Intermittent Drug Regimen Harmless Virus Associated With Longer Life for Some HIV-Positive Men Scientists Find HIV-Blocking Protein in Monkeys HHS Secretary Names Five to NIAID Advisory Council RV144, an Ongoing HIV Vaccine Efficacy Trial in Thailand
Combination, Order of Anti-HIV Drugs Make a Difference in First-Time Recipients Understanding the Immune System: How It Works Treatment Interruption Shows No Benefit in Drug-Resistant HIV Infection HIV Infection in Minority Populations Understanding Vaccines: What They Are, How They Work Topical Microbicides: Preventing Sexually Transmitted Diseases International HIV Vaccine Awareness Day: May 18, 2003 Many Americans Think an HIV/AIDS Vaccine Already Exists HIV Infection in Adolescents Discovery Lays Groundwork for Potential New Class of Anti-HIV Drugs Trizivir-Only Arm Closed in PI-Sparing, Naive Therapy Trial here
National Black HIV/AIDS Awareness Day
Statement of Anthony S. Fauci, M.D. on World AIDS Day Family Focus Is Hallmark of New South African Grant Study Shows Why Some Immune Systems Control HIV NIAID Teams With Wyeth on HIV/AIDS Vaccine HIV Vaccine Research Is "Best Hope" for Controlling AIDS Pandemic HIV Selectively Suppresses Anti-HIV Defense Cells New Awards, Expanded Focus for Pediatric AIDS Clinical Trials Group NIAID Phase III HIV Vaccine Trial to Determine Correlates of Protection Will Not Proceed The SMART Way to Fight AIDS
NIAID and Merck to Collaborate on HIV Vaccine Development New Findings Explain T-Cell Loss in HIV Infection Garlic Supplements Can Impede HIV Medication 7-Day-On, 7-Day-Off Regimen Could Reduce Cost, Toxicities of HIV Therapy New NIH Web Resource Marks World AIDS Day World AIDS Day, December 1, 2001 New Finding May Help Doctors Prevent HIV Drug Resistance HIV "Rides" into Cells on Membrane Rafts, NIAID Scientists Determine High HIV Levels Shut Down Anti-HIV Immune Responses First AIDS Vaccine Made at NIAID's Vaccine Research Center Enters Clinical Trial Anthony S. Fauci Awarded 2001 Frank Annunzio Award Major AIDS Studies to Increase Minority Enrollment, Answer New Questions Fauci to Present AIDS Vaccine Update at Philadelphia Meeting NIAID Researchers Identify HIV-Induced Changes in B Cells NIH Launches Online AIDS Oral History Project Fourth Annual HIV Vaccine Awareness Day Honors Volunteers, Promotes Research A Parasite, a Virus, and a Bacterium: NIAID's Plan to Tackle the World's Leading Killers NIAID Global Health Research Plan for HIV/AIDS, Malaria, and Tuberculosis New Prime-Boost HIV Vaccine Strategy Shows Promise in Monkeys Study Confirms Gender Differences in Progression from HIV to AIDS: Despite Differences in "Viral Load," Men and Women Develop AIDS at the Same Rate HIV Treatment Guidelines Updated for Adults and Adolescents NIH Scientists Highlight Role of Macrophages in HIV Infection
World AIDS Day: Statement of Anthony S. Fauci, M.D., Director, NIAID/NIH NIH Announces New Plan for Global AIDS Research T Cell's Internal "Housekeeping Service" Plays Role in HIV Infection Researchers Identify New Genetic Risk Factor for HIV Infection Interleukin-2 May Help Patients with Advanced HIV Disease, New Study Shows Promising HIV Vaccine Strategy Identified in Monkey Studies NIH Study Demonstrates Surprising Complication in HIV Infection B Cells May Help Maintain HIV Infection Identification of Yeast Mating Habits Opens New Doors to Candida Research Inexpensive AIDS Drug Still Reduces HIV Transmission from Mother to Child After One Year NIH Announces New International Network to Study HIV Prevention Strategies NIAID Creates Global Network to Advance Development of HIV Vaccines Fauci Presents New Data on Structured Intermittent Therapy at XIIIth World AIDS Conference in Durban, South Africa Adding IL-2 to Potent Anti-HIV Drugs Increases CD4+ T-Cell Counts Without Raising HIV Levels NIAID Creates Global Network to Advance Development of HIV Vaccines Third Annual HIV Vaccine Awareness Day Honors Volunteers, Promotes Research NIAID Topical Microbicide Research Fact Sheet NIAID Researchers Discover Why Some HIV-Infected People Don't Develop AIDS
NIAID Renews Funding for the Adult AIDS Clinical Trials Group Molecular Traffic Signal Could Be New HIV Drug Target Rapid Rebound of HIV and Reappearance of HIV Reservoirs in Patients Treated with IL-2 and Combination Antiretroviral Drugs Following Cessation of Therapy New Model Suggests that AIDS Drugs May Not Abolish HIV Infection Study Finds HIV Breastfeeding Risk Highest in Early Months After Birth Researchers Identify a Simple, Affordable Drug Regimen That Is Highly Effective in Preventing HIV Infection in Infants of Mothers With the Disease Combination HIV Vaccine Induces Diverse Immune Responses New Anti-HIV Therapies Needed to Eradicate HIV Status of AIDS Vaccine Research at the National Institutes of Health (NIH) Second Annual AIDS Vaccine Day Honors Volunteers Nationwide Newly Updated HIV Treatment Guidelines for Adults and Adolescents Available on the World Wide Web Immune Response to Hepatitis B Spares Liver Cells The Role of CD8+ Lymphocytes in the Control of SIV Viremia NIAID Opens First AIDS Vaccine Trial in Africa New Studies Offer Clues to AIDS Vaccine Design and Safety NIAID-Supported Scientists Discover Origin of HIV-1 Reassuring Findings about Infants Exposed to Zidovudine Hepatitis C: A Meeting Ground for the Generalist and the Specialist
Study Offers Hope for Immune Reconstitution After HIV Infection Treatment with IL-2 Plus HAART Markedly Reduces HIV in Immune System "Hiding Places" Study Finds Less Intensive Treatments May Not Maintain HIV Suppression Innovative Database Developed for the Study of Sexually Transmitted Diseases Study Shows Efavirenz Promising in Treating Pediatric HIV Infection NIAID Scientists Discover HIV Disease-Slowing Mutation Pool of Latently Infected, "Resting" Cells Established Early in HIV Infection The Perils of Discontinuing Therapy: Without HAART, Cytokines Stimulate HIV From Latently Infected Cells Mass Treatment for Curable STDs Has Mixed Results, Study Finds: Some STD Rates Fall, But HIV Incidence Remains Unchanged Scientists Make Progress Toward Gene Therapy for HIV Infection HIV/AIDS in 1998 -- Gaining the Upper Hand? The Journal of the American Medical Association
Crystal Structure of Key HIV Protein Reveals New Prevention, Treatment Targets Scientists Say Latently Infected Cells May Stoke the Fire of HIV Replication First Human Trial Shows that an Edible Vaccine is Feasible Short-Course TB Prophylaxis Effective in HIV-Infected Individuals Fauci: New Findings Help Explain "Rebound" of HIV in Patients Who Discontinue Triple-Drug Therapy Novel Concepts Put to the Test in Three New AIDS Vaccine Trials
Studies Shed New Light on HIV Epidemic in India HIV Persists and Can Replicate Despite Prolonged Combination Therapy Clinical Implications of Resistance to Antiretroviral Drugs Update from the June 1997 International Workshop on HIV Drug Resistance, Treatment Strategies and Eradication HIV Subterfuge Revealed Mutant Gene Not Sole Explanation for HIV Non-Progression "Trojan Horse" Virus Controls HIV Infection Researchers Clone Infectious Hepatitis C Virus Limited Course of Thalidomide Effective in Treating AIDS-Related Mouth Ulcers Challenges in Designing HIV Vaccines Clinical Research on HIV/AIDS Vaccines Panel Affirms Importance of Prenatal AZT Use Study Confirms that Protease Inhibitor Cocktail Can Delay HIV Disease Progression and Death
Advertisement
E-Mail
Printer Friendly
Glossary
Share
